| 000 | 01915cam a2200313 i 4500 | ||
|---|---|---|---|
| 999 |
_c12844 _d12844 |
||
| 001 | 47216645 | ||
| 005 | 20210304143951.0 | ||
| 008 | 010615s2001 nyua b 001 0 eng | ||
| 010 | _a2001042174 | ||
| 020 | _a0824705807 (alk. paper) | ||
| 040 |
_aDLC _cDLC _dEG-NcFUE _beng _erda |
||
| 050 | 0 | 0 |
_aRM301.63 _b.D784 2001 |
| 082 | 0 | 4 |
_a615.6 _222 _bD |
| 245 | 0 | 0 |
_aDrug targeting technology : _bphysical, chemical, biological methods / _cedited by Hans Schreier |
| 264 | 1 |
_aNew York : _bMarcel Dekker, _c2001. |
|
| 300 |
_ax, 294 pages : _billustrations ; _c24 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 490 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 115 |
|
| 504 | _aIncludes bibliographical references and index | ||
| 505 | 0 | _aPt.1. Physical targeting approaches -- Enteric targeting through enteric coating -- New experimental coating material for colon-specific drug delivery -- Pharmacokinetic considerations in the design of pulmonary drug delivery sysystems for gluccocorticoids -- Lipid-based formulations for oral administration: opportunities for bioavailability enchancement and lipoprotein targeting of lipophilic drugs -- Topical application of drugs: mechanisms involved in chemical enhancement -- Pt.2. Chemical targeting approaches -- Drug targeting by retrometabolic design: soft drugs and chemical delivery systems -- Neoglyco- and neopeptide albumins for cell-specific delivery of drugs to chronically diseases livers -- Pt.3. Biological targeting approaches -- Gene delivery with artificial viral envelopes -- Evolution of viral liposomes: improvements and applications -- Targeting of viral vectors for cancer gene therapy | |
| 650 | 0 | _aDrug targeting | |
| 650 | 2 | _aDrug Delivery Systems | |
| 650 | 2 | _aDrug Administration Routes | |
| 700 | 1 |
_aSchreier, Hans, _d1949- |
|
| 942 |
_2ddc _cBK |
||